TOP STORIES

• BUSINESS BMS Japan Launches New Head Office as It Looks to Spur Ideas through Casual Chats
  July 5, 2022

• BUSINESS Chugai Best-Paying Japan Pharma in FY2021, 25 Drug Makers Pay Average 8.33 Million Yen
  July 4, 2022

• BUSINESS 37 Pharma Execs Get 100 Million-Plus Yen in FY2021, Top 3 at Takeda: Securities Reports
  July 1, 2022

• REGULATORY Japan Begins TPOXX Clinical Research as It Braces for Monkeypox Outbreak
  June 30, 2022

• BUSINESS Wholesalers Bear Over 50 Billion Yen in Annual Costs Tied to Restricted Drug Supply: Crecon Estimate
  June 29, 2022

• BUSINESS Astellas/Sutro to Codevelop Next-Gen Immunostimulatory ADCs for Cold Tumors
  June 29, 2022

• BUSINESS Bimzelx as Driver, UCB Set to Derive Half of Global Sales from Immunology Biz
  June 28, 2022

• COMMENTARY Japan Should Accelerate Debate on Legalizing Cannabis-Derived Drugs for Refractory Epilepsies
  June 27, 2022

• ORGANIZATION Kichiro Matsumoto Elected as New Chief of Japan Medical Association
  June 27, 2022

• BUSINESS 25 Japan Drug Makers Log Combined 10.7% Growth in FY2021, 12 See Two-Digit Jumps: Tally
  June 24, 2022

• REGULATORY Japan Shelves Decision on Shionogi’s COVID Pill with Experts at Odds, Another Session Likely Next Month
  June 23, 2022

• BUSINESS Biosimilars Likely to Gain Further Impetus from Govt Push; Forteo/Enbrel Hit 40% Share, Herceptin 50%-Plus
  June 22, 2022

• REGULATORY Kazuhiro Oshima Tapped as Vice Health Minister, Katsufumi Jo as First Councilor for Pharma Industry Promotion
  June 22, 2022

• REGULATORY Japan Approves Janssen’s COVID Jab, Sanofi’s Sutimlimab, Olumiant’s Alopecia Use and More
  June 21, 2022

• BUSINESS Astellas Workforce Down by More than 700: Securities Report
  June 21, 2022

• BUSINESS PeptiDream Set to Develop Peptide-RI Conjugates for Refractory Cancers, Eyes No. 1 Spot in Radiotherapy
  June 20, 2022

• REGULATORY As Election Campaigns Begin, Parties Pitch Policies to Bolster Drug Development, Supply Chains
  June 17, 2022

• BUSINESS Patent Rows Don’t Stop Generic Players; Single Entries, AG Non-Launches Seen in June Listing
  June 17, 2022

• REGULATORY Feburic, Samsca, and More Face First Generics in June Listing, No Xarelto/Eylea AGs
  June 16, 2022

• REGULATORY Kishida Officially Unveils Plan to Form Pandemic Response Agency, Japan CDC
  June 16, 2022

ページ

• « 先頭
• ‹ Prev
• …
• 65
• 66
• 67
• 68
• 69
• 70
• 71
• 72
• 73
• …
• Next ›
• 最終 »